Published peptide research references
Major proglucagon fragment
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study.
Source identity and connection checked by Codex (AI).
Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
Source identity and connection checked by Codex (AI).
Expression, purification, and PC1-mediated processing of human proglucagon, glicentin, and major proglucagon fragment.
DOI: 10.1016/s1046-5928(02)00653-8
Source identity and connection checked by Codex (AI).
Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review.
DOI: 10.1007/s13679-026-00687-7
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Bonic A
- Mackin RB
- Tzeravini E
- Simati S
- Anastasiou IA
- Dalamaga M
- Kokkinos A
- Stefanakis K
- Argyrakopoulou G
- Konstantinidou SK
- Kouvari M
- Kumar A
- Kalra B
- Kumar M
- Bontozoglou N
- Kyriakopoulou K
- Mantzoros CS
- Kim SH
- Abbasi F
- Nachmanoff C
- Savjani G